Montanova Capital LLC Sells 36,500 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Montanova Capital reduced its UnitedHealth Group stake by 36.3% in the second quarter, selling 36,500 shares and retaining 64,130 shares valued at approximately $26.7 million. Institutional investors collectively own 87.86% of UNH.
• Wall Street remains broadly positive, with a consensus “Moderate Buy” rating and an average price target of $456.56; several analysts recently raised their targets.
• UnitedHealth reported quarterly EPS of $6.38, exceeding estimates by $1.44, and revenue of $112.03 billion. The company also declared a quarterly dividend of $2.32 per share, equivalent to a 2.4% annualized yield.

Montanova Capital LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 36.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 64,130 shares of the healthcare conglomerate's stock after selling 36,500 shares during the quarter. Montanova Capital LLC's holdings in UnitedHealth Group were worth $26,654,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Anfield Capital Management LLC grew its holdings in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 55 shares during the last quarter. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. Finally, Wilkerson Advisory Group LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $30,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Barclays boosted their price target on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a report on Monday, July 20th. Royal Bank Of Canada boosted their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the stock an "outperform" rating in a research report on Friday, July 17th. HC Wainwright set a $492.00 price target on shares of UnitedHealth Group in a report on Wednesday, May 27th. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Finally, HSBC increased their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a report on Monday, July 6th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $456.56.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.19% of the company's stock.

UnitedHealth Group Stock Down 0.8%

UNH opened at $389.92 on Tuesday. The company has a market cap of $349.99 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62. The company has a 50 day moving average of $412.95 and a 200 day moving average of $361.54. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same period last year, the company earned $4.08 earnings per share. The business's revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source